30 April 2015 - Deborah Wilkes
Archived
Perrigo's board has rejected a third takeover offer from generics company Mylan, which is itself fending off a hostile takeover offer from Israeli generics giant Teva.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.